Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2238-2244
Published online before print May 1, 2006, doi: 10.1161/CIRCULATIONAHA.105.599175
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/18/2238    most recent
CIRCULATIONAHA.105.599175v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenhek, R.
Right arrow Articles by Baumgartner, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenhek, R.
Right arrow Articles by Baumgartner, H.
Related Collections
Right arrow Valvular heart disease
Right arrowRelated Article

(Circulation. 2006;113:2238-2244.)
© 2006 American Heart Association, Inc.


Valvular Heart Disease

Outcome of Watchful Waiting in Asymptomatic Severe Mitral Regurgitation

Raphael Rosenhek, MD; Florian Rader, MD; Ursula Klaar, MD; Harald Gabriel, MD; Marcel Krejc, PhD; Daniel Kalbeck, PhD; Michael Schemper, PhD; Gerald Maurer, MD; Helmut Baumgartner, MD

From the Department of Cardiology (R.R., F.R., U.K., H.G., M.K., D.K., G.M., H.B.) and the Core Unit for Medical Statistics and Informatics (M.S.), Medical University of Vienna, Vienna, Austria.

Correspondence to Raphael Rosenhek, MD, or Helmut Baumgartner, MD, Department of Cardiology, Medical University of Vienna, Waehringer Gürtel 18-20, A-1090 Vienna, Austria. E-mail raphael.rosenhek{at}meduniwien.ac.at or helmut.baumgartner@meduniwien.ac.at

Received November 2, 2005; revision received February 9, 2006; accepted February 17, 2006.

Background— The management of asymptomatic severe mitral regurgitation remains controversial. The aim of this study was to evaluate the outcome of a watchful waiting strategy in which patients are referred to surgery when symptoms occur or when asymptomatic patients develop left ventricular (LV) enlargement, LV dysfunction, pulmonary hypertension, or recurrent atrial fibrillation.

Methods and Results— A total of 132 consecutive asymptomatic patients (age 55±15 years, 49 female) with severe degenerative mitral regurgitation (flail leaflet or valve prolapse) were prospectively followed up for 62±26 months. Patients underwent serial clinical and echocardiographic examinations and were referred for surgery when the criteria mentioned above were fulfilled. Overall survival was not statistically different from expected survival either in the total group or in the subgroup of patients with flail leaflet. Eight deaths were observed. Thirty-eight patients developed criteria for surgery (symptoms, 24; LV criteria, 9; pulmonary hypertension or atrial fibrillation, 5). Survival free of any indication for surgery was 92±2% at 2 years, 78±4% at 4 years, 65±5% at 6 years, and 55±6% at 8 years. Patients with flail leaflet tended to develop criteria for surgery slightly but not significantly earlier. There was no operative mortality. Postoperative outcome was good with regard to survival, symptomatic status, and postoperative LV function.

Conclusions— Asymptomatic patients with severe degenerative mitral regurgitation can be safely followed up until either symptoms occur or currently recommended cutoff values for LV size, LV function, or pulmonary hypertension are reached. This management strategy is associated with good perioperative and postoperative outcome but requires careful follow-up.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2006 113: 2165. [Full Text]



This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
F. Grigioni, C. Tribouilloy, J. F. Avierinos, A. Barbieri, M. Ferlito, F. Trojette, L. Tafanelli, A. Branzi, C. Szymanski, G. Habib, et al.
Outcomes in Mitral Regurgitation Due to Flail Leaflets: A Multicenter European Study
J. Am. Coll. Cardiol. Img., March 1, 2008; 1(2): 133 - 141.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
P. A. Grayburn
Should We Operate on Asymptomatic Patients With Severe Mitral Regurgitation?
J. Am. Coll. Cardiol. Img., March 1, 2008; 1(2): 142 - 144.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. J. Kerr, O. C. Raffel, G. A. Whalley, I. Zeng, and R. A. Stewart
Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation
Eur. Heart J., February 1, 2008; 29(3): 363 - 370.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
J. I. Fann, N. B. Ingels Jr., and D. C. Miller
Pathophysiology of Mitral Valve Disease
Card. Surg. Adult, January 1, 2008; 3(2008): 973 - 1012.
[Full Text]


Home page
CirculationHome page
T. Feldman and M. B. Leon
Prospects for Percutaneous Valve Therapies
Circulation, December 11, 2007; 116(24): 2866 - 2877.
[Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
R. Lee and T. H. Marwick
Assessment of subclinical left ventricular dysfunction in asymptomatic mitral regurgitation
Eur J Echocardiogr, June 1, 2007; 8(3): 175 - 184.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. H. Jones
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol., May 8, 2007; 49(18): 1887 - 1898.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]


Home page
CirculationHome page
M. G. St. John Sutton and R. C. Gorman
Surgery for Asymptomatic Severe Mitral Regurgitation in the Elderly: Early Surgery or Wait and Watch?
Circulation, July 25, 2006; 114(4): 258 - 260.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
For Asymptomatic Severe MR, Watch and Wait?
Journal Watch Cardiology, June 28, 2006; 2006(628): 3 - 3.
[Full Text]


Home page
CirculationHome page
B. P. Griffin
Timing of Surgical Intervention in Chronic Mitral Regurgitation: Is Vigilance Enough?
Circulation, May 9, 2006; 113(18): 2169 - 2172.
[Full Text] [PDF]